Evidence map›Paper›PMID 39125882›Full record

ReviewInternational journal of molecular sciences2024

Neurotrophins and Their Receptors: BDNF's Role in GABAergic Neurodevelopment and Disease.

Carlos Hernández-Del Caño, Natalia Varela-Andrés, Alejandro Cebrián-León, Rubén Deogracias

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Carlos Hernández-Del CañoInstituto de Neurociencias de Castilla y León (INCyL), 37007 Salamanca, Spain.ORCID 0009-0003-4223-936X
Natalia Varela-AndrésInstituto de Neurociencias de Castilla y León (INCyL), 37007 Salamanca, Spain.ORCID 0000-0003-3334-7521
Alejandro Cebrián-LeónInstituto de Neurociencias de Castilla y León (INCyL), 37007 Salamanca, Spain.ORCID 0000-0003-2779-7657
Rubén DeograciasInstituto de Neurociencias de Castilla y León (INCyL), 37007 Salamanca, Spain.ORCID 0000-0002-9279-7867

Funding

Spanish Ministry of Science and Innovation RYC2018/205215-I, PID2020-113086RB-I00, CNS2022-136048
6 · The paper itself

Abstract

Neurotrophins and their receptors are distinctly expressed during brain development and play crucial roles in the formation, survival, and function of neurons in the nervous system. Among these molecules, brain-derived neurotrophic factor (BDNF) has garnered significant attention due to its involvement in regulating GABAergic system development and function. In this review, we summarize and compare the expression patterns and roles of neurotrophins and their receptors in both the developing and adult brains of rodents, macaques, and humans. Then, we focus on the implications of BDNF in the development and function of GABAergic neurons from the cortex and the striatum, as both the presence of BDNF single nucleotide polymorphisms and disruptions in BDNF levels alter the excitatory/inhibitory balance in the brain. This imbalance has different implications in the pathogenesis of neurodevelopmental diseases like autism spectrum disorder (ASD), Rett syndrome (RTT), and schizophrenia (SCZ). Altogether, evidence shows that neurotrophins, especially BDNF, are essential for the development, maintenance, and function of the brain, and disruptions in their expression or signaling are common mechanisms in the pathophysiology of brain diseases.

Indexed as

Brain-Derived Neurotrophic FactorGABAergic NeuronsAnimalsBrainHumansNerve Growth FactorsNeurodevelopmental DisordersReceptors, Nerve Growth FactorBrain-Derived Neurotrophic FactorNerve Growth FactorsReceptors, Nerve Growth FactorautismBDNFGABAergic neuronsneurodevelopmentneurotrophinsRett syndromeschizophreniaTrkB

Identifiers

PMID39125882
PMCPMC11311851

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.